Skip to main content

View full-text article in PMC

. 2019 Jul 9;11:99. doi: 10.1186/s13148-019-0693-2

Table 1.

Correlation between SLCO4C1 DNA promoter methylation and clinicopathological parameters

Variable	All patients	cg22149516 (P value)	cg06480736 (P value)	cg19788741 (P value)	cg19774478 (P value)
Patient number	498
Age (years)
> 60	247
≤ 60	251	0.09^a	0.04^a	0.03^a	0.36^a
Tumour category
pT2	188
pT3 and pT4	303
Unknown	7	0.02^a	< 0.01^a	< 0.01^a	< 0.01^a
Gleason score
< 7	45
3 + 4	147
4 + 3	101
= 8	64
> 8	141	0.28^a	< 0.01^a	< 0.01^a	< 0.01^a
Surgical margin
R0	316
R1, R2 and RX	162
Unknown	20	0.06^a	< 0.01^a	< 0.01^a	0.02^a
Nodal category
pN0	346
pN1	79
Unknown	73	0.18^a	0.02^a	0.01^a	0.01^a
Preoperative PSA [ng/ml]
0~4	51
4–10	286
> 10	153
Unknown	8	0.64^b	0.28^b	0.42^b	0.25^b

^aMann-Whitney U test

^bKruskal-Wallis test